Amneal Pharmaceuticals, Inc. (AMRX)

CIK 1723128 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Amneal Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 3, 20268-K0001723128-26-000035
Oct 23, 20268-K/A0001140361-26-040656
Sep 21, 202640001628280-26-062915
Sep 14, 202640001628280-26-061836
Sep 3, 2026S-3ASR0001140361-26-035617
Sep 2, 202640001628280-26-060179
Aug 25, 202640001628280-26-058918
Aug 14, 202640001628280-26-057147
Aug 13, 202640001628280-26-056754
Aug 13, 202640001628280-26-056752
Aug 13, 20261440001628280-26-056733
Aug 13, 202640001628280-26-056757
Aug 12, 202640000898432-26-000655
Aug 12, 20261440001628280-26-056220
Aug 12, 20261440001628280-26-056196
Aug 12, 202640001628280-26-056285
Aug 12, 2026SCHEDULE 13D/A0000898432-26-000654
Aug 12, 2026SCHEDULE 13D/A0000898432-26-000652
Aug 12, 2026SCHEDULE 13D/A0000898432-26-000653
Aug 12, 202640001628280-26-056288
Aug 12, 202640001628280-26-056297
Aug 11, 20261440001949846-26-000494
Aug 10, 20268-K0001140361-26-032014
Aug 6, 202610-Q0001723128-26-000031
Aug 3, 20268-K0001628280-26-051900